1. MARKETS
  2. SECTOR : DIVERSIFIED CONSUMER SERVICES
  3. INDUSTRY : HEALTHCARE SERVICES
  4. 20/20 BIOLABS INC
20/20 Biolabs Inc
XNAS: AIDX
0.53 0.00 (0.00%)
53,458.3
XNAS Volume

XNAS 17 Jul, 2026 10:55 AM (EDT)

Watchlist

Portfolio

Alert



Insider Trading disclosures for 2020 Biolabs Inc

The latest disclosure was made by Alan B. Bergman in 2020 Biolabs Inc where a trade of 100,000 Stock Option done was reported to US exchanges on April 2, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Alan B. Bergman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Apr 2026 100,000 100,000 - - Stock Option
Jiming Zhou Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Apr 2026 150,000 150,000 - - Stock Option
Jonathan M Cohen Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2026 352,936 352,936 - - Stock Option
Richard M. Cohen Director 19 Feb 2026 7,700 0 - - Series A-2 Preferred Stock
Richard M. Cohen Director 19 Feb 2026 7,700 7,700 - 0 Common Stock
John G Compton Director 19 Feb 2026 7,669 14,335 - 0 Common Stock
John G Compton Director 19 Feb 2026 7,669 0 - - Series A-2 Preferred Stock
John Woodson Rollins Director 19 Feb 2026 13,029 24,140 - 0 Common Stock
John Woodson Rollins Director 19 Feb 2026 13,029 0 - - Series A Preferred Stock
John Woodson Rollins Director 19 Feb 2026 6,135 0 - - Series A-2 Preferred Stock
John Woodson Rollins Director 19 Feb 2026 6,135 30,275 - 0 Common Stock
Michael A. Ross Director 19 Feb 2026 31 0 - - Series A-2 Preferred Stock
Michael A. Ross Director 19 Feb 2026 31 31 - 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures